Shabir Madhi
South Africa Begins First COVID-19 Vaccine Trial
Sourced from Getty Images The University of Witswatersrand has announced that South Africa’s first COVID-19 vaccine trial is set to begin, with participants to be enrolled by the end of the week. “This is a landmark moment for South Africa and Africa at this stage of the COVID-19 pandemic. As we enter winter in South Africa and pressure increases on public hospitals, now more than ever we need a vaccine to prevent infection by COVID-19,” Professor of Vaccinology at Wits University and Director of the South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Shabir Madhi, says in a virtual briefing. This new trial aims to find a vaccine that will prevent SARS-CoV-2 infection, which is the virus that causes COVID-19. “We began screening participants for ...
South Africa’s mass testing hits limits as virus spreads
With an expert flick of the wrist, South African nurse Bhelekazi Mdlalose collected throat swabs from young men lining up for coronavirus testing at a run-down hostel in downtown Johannesburg. Health workers were sent to the overcrowded block of single-room flats — mainly occupied by men from rural areas doing odd jobs in the city — as part of a mass community screening and testing (CST) campaign launched by the government last month. Mdlalose, who is employed by Doctors Without Borders (MSF), left her family and usual job in the northwestern town of Rustenberg in March to support community work in Johannesburg. Aged 51, she trains government health workers to handle suspected coronavirus patients correctly, checking in on CST teams deployed to townships, offices and shopping malls. “We id...
